Brivaracetam

FDA Approved: * October 3, 2022
Pharm Company: * ZYDUS PHARMS USA
Category: Anticonvulsant

Brivaracetam, sold under the brand names Briviact and Brivajoy among others, a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties.[2][3] It is marketed by the pharmaceutical company UCB.[4][5] In India it is co-promoted and distributed by Dr. Reddy's Laboratories.[not verified in body] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Brivaracetam 10 mg/ml Oral Solution
NDC: 0121-1074
Labeler:
Pai Holdings, LLC Dba Pai Pharma
Brivaracetam 50 mg/5ml Intravenous Injection
NDC: 0121-1075
Labeler:
Pai Holdings, LLC Dba Pai Pharma
Brivaracetam 50 mg/5ml Intravenous Injection
NDC: 14335-420
Labeler:
Hainan Poly Pharm. Co., Ltd.
Brivaracetam 50 mg/5ml Intravenous Injection
NDC: 42571-370
Labeler:
Micro Labs Limited
Brivaracetam 10 mg Oral Tablet
NDC: 60505-4723
Labeler:
Apotex Corp.
Brivaracetam 25 mg Oral Tablet
NDC: 60505-4724
Labeler:
Apotex Corp.
Brivaracetam 50 mg Oral Tablet
NDC: 60505-4725
Labeler:
Apotex Corp.
Brivaracetam 75 mg Oral Tablet
NDC: 60505-4726
Labeler:
Apotex Corp.
Brivaracetam 100 mg Oral Tablet
NDC: 60505-4727
Labeler:
Apotex Corp.
Brivaracetam Oral Solution Oral Solution 10 mg/ml Oral Solution
NDC: 67877-904
Labeler:
Ascend Laboratories, LLC
More Results

Related Brands

Drugs with the same active ingredients